Novo Nordisk A/S (OCSE:NOVO B)
kr 927.3 10.4 (1.13%) Market Cap: 4.13 Til Enterprise Value: 4.15 Til PE Ratio: 46.58 PB Ratio: 41.83 GF Score: 93/100

Novo Nordisk A/S ESG Conference Call Transcript

Nov 30, 2020 / 03:00PM GMT
Release Date Price: kr209.85 (+0.11%)
Operator

Hello, and welcome to the Novo Nordisk A/S conference call. (Operator Instructions) Today, I'm pleased to present Lars Fruergaard Jørgensen, CEO. Please go ahead with your meeting.

Lars Fruergaard JÃ;rgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

¸ - /- -

Thank you very much, and welcome to this conference call regarding our approach to sustainability.

With me today, I have Camilla Sylvest, Executive Vice President and Head of Commercial Strategy and Corporate Affairs. I also have Henrik Wulff, Executive Vice President of Product Supply, Quality and IT. I also have Monique Carter, Executive Vice President of People and Organization. And finally, I have Karsten Munk Knudsen, Executive Vice President and Chief Financial Officer.

Please turn to Slide 2. We will to today be making forward-looking statements, and I have to remind you that such forward-looking statements would include risks and uncertainties. So please look at Slide 2 and also make reference to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot